Drugs / TD-1439
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02954263 | Nov 2016 → Feb 2017 | — | Theravance Biopharma | Completed | No outcome recorded |
| Phase 1 | NCT02903095 | Sep → Dec 2016 | — | Theravance Biopharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TD-1439 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02954263 ↗ |